Effects Of GW679769 On Sleep Onset And Maintenance And Next Day Functioning In Subjects With Primary Insomnia
NCT00280423
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
342
Enrollment
INDUSTRY
Sponsor class
Conditions
Sleep Initiation and Maintenance Disorders
Insomnia
Interventions
DRUG:
GW679769
Sponsor
GlaxoSmithKline